 |
 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 July 1993 | Volume 119 Issue 1 | Pages 23-27
Objective: To compare the dose effectiveness of low to moderate doses of methadone in a sample of a contemporary population of opioid abusers, because the optimal dosing of methadone in the treatment of opioid dependence remains an issue.
Design: A randomized, double-blind, placebo-controlled study.
Setting: A methadone treatment research clinic.
Patients: Participants (n = 247) were opioid-dependent patients with a high rate of cocaine use.
Intervention: All participants were initially treated with active methadone for a minimum of 5 weeks and then received 15 weeks of stable dosing at 50, 20, or 0 mg per day. Individual counseling and group therapy were included.
Measurements: Treatment retention and illicit drug use as determined by intensive urine monitoring.
Results: Retention was better for patients who remained on active medication. By treatment week 20, retention was 52.4% for the 50-mg, 41.5% for the 20-mg, and 21.0% for the 0-mg group (50 versus 0 and 20 versus 0, P < 0.05; 50 versus 20, P > 0.05). Only the 50-mg treatment group had a reduced rate of opioid-positive urine samples (56.4% versus 67.6% and 73.6% for the 20-mg and 0-mg groups, respectively; P < 0.05) and cocaine-positive urine samples (52.6% versus 62.4% and 67.1% for the 20- and 0-mg groups, respectively; P < 0.05).
Conclusions: There is a dose-response effect for methadone treatment. Doses as low as 20 mg may improve retention but are inadequate for suppressing illicit drug use.
Author and Article Information
From Johns Hopkins University School of Medicine, Baltimore, Maryland.
ARTICLE
Dose-Response Effects of Methadone in the Treatment of Opioid Dependence
Requests for Reprints: Eric C. Strain, MD, The Department of Psychiatry, Johns Hopkins University School of Medicine, Francis Scott Key Medical Center, 4940 Eastern Avenue, Baltimore, MD 21224.
Acknowledgments: The authors thank the clinic and research staff for their assistance in the execution of this study.
Grant Support: By USPHS grant R01-DA05792.
This article has been cited by other articles:
|
|
 |
|
  E. F. Wedam, G. E. Bigelow, R. E. Johnson, P. A. Nuzzo, and M. C. P. Haigney QT-Interval Effects of Methadone, Levomethadyl, and Buprenorphine in a Randomized Trial Arch Intern Med, December 10, 2007; 167(22): 2469 - 2475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Vocci, J. Acri, and A. Elkashef Medication Development for Addictive Disorders: The State of the Science Am J Psychiatry, August 1, 2005; 162(8): 1432 - 1440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Schottenfeld, M. C. Chawarski, J. R. Pakes, M. V. Pantalon, K. M. Carroll, and T. R. Kosten Methadone Versus Buprenorphine With Contingency Management or Performance Feedback for Cocaine and Opioid Dependence Am J Psychiatry, February 1, 2005; 162(2): 340 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Brown, C Kraus, M Fleming, and S Reddy Methadone: applied pharmacology and use as adjunctive treatment in chronic pain Postgrad. Med. J., November 1, 2004; 80(949): 654 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Krantz and P. S. Mehler Treating Opioid Dependence: Growing Implications for Primary Care Arch Intern Med, February 9, 2004; 164(3): 277 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Clark High dose buprenorphine may be an effective interim treatment for long term heroin users waiting for drug-assisted rehabilitation Evid. Based Ment. Health, February 1, 2003; 6(1): 30 - 30. [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Johnson, M. A. Chutuape, E. C. Strain, S. L. Walsh, M. L. Stitzer, and G. E. Bigelow A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence N. Engl. J. Med., November 2, 2000; 343(18): 1290 - 1297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. O'Connor and D. A. Fiellin Pharmacologic Treatment of Heroin-Dependent Patients Ann Intern Med, July 4, 2000; 133(1): 40 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Preston, A. Umbricht, and D. H. Epstein Methadone Dose Increase and Abstinence Reinforcement for Treatment of Continued Heroin Use During Methadone Maintenance Arch Gen Psychiatry, April 1, 2000; 57(4): 395 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Strain, G. E. Bigelow, I. A. Liebson, and M. L. Stitzer Moderate- vs High-Dose Methadone in the Treatment of Opioid Dependence: A Randomized Trial JAMA, March 17, 1999; 281(11): 1000 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Farrell, J Ward, R Mattick, W Hall, G V Stimson, D des Jarlais, M Gossop, and J Strang Fortnightly Review: Methadone maintenance treatment in opiate dependence: a review BMJ, October 15, 1994; 309(6960): 997 - 1001. [Full Text]
|
|
|
|
 |
|
 METHADONE DOSING IN OPIOID DEPENDENCE Journal Watch (General), July 9, 1993; 1993(709): 5 - 5. [Full Text]
|
|
Article
